<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21249">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02830243</url>
  </required_header>
  <id_info>
    <org_study_id>2016-05-058</org_study_id>
    <nct_id>NCT02830243</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Effect of Volatile Anesthetics</brief_title>
  <official_title>The Comparison of Analgesic Effect of Volatile Anesthetics Using Surgical Pleth Index</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kangbuk Samsung Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kangbuk Samsung Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to compare analgesic effect of sevoflurane and
      desflurane at equal minimum alveolar concentrations using surgical pleth index.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Volatile anesthetics vary in their relative hypnotic potency. Recent studies demonstrated
      that equi-minimum alveolar concentration of various volatile anesthetic agents may produce
      different bispectral index values. However, the difference between analgesic effects of
      volatile anesthetics have not yet been investigated. The purpose of this clinical trial is
      to compare analgesic effect of sevoflurane and desflurane at equal minimum alveolar
      concentrations using surgical pleth index-guided remifentanil infusion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remifentanil consumption (Âµg/kg/min)</measure>
    <time_frame>During the intraoperative period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target effective site concentration of remifentanil (ng/ml)</measure>
    <time_frame>After at least 10 min of stable surgical pleth index values</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia was maintained with sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia was maintained with desflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>End-tidal concentration of sevoflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period. The remifentanil infusion rate was adjusted using TCI pump to achieve surgical pleth index between 20 and 50.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>SEVO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>End-tidal concentration of desflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period. The remifentanil infusion rate was adjusted using TCI pump to achieve surgical pleth index between 20 and 50.</description>
    <arm_group_label>Desflurane</arm_group_label>
    <other_name>DES</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing balanced general anesthesia using volatile anesthetics and
             remifentanil

          -  patients with american society of anesthesiologist physical status I, II

          -  patients aged 19-65 years

          -  patients obtaining written informed consent

        Exclusion Criteria:

          -  patients with a history of any psychiatric or neurological disease

          -  patients who had received any medication affecting the central nervous system

          -  patients who had received medication affecting the sympathetic or parasympathetic
             nervous systems

          -  patients undergoing tracheal intubation for airway management

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyoungho Ryu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangbuk Samsung Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyoungho Ryu, M.D.</last_name>
    <phone>+82-2-2001-1376</phone>
    <email>drkhryu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyoungho Ryu, M.D.</last_name>
      <phone>+82-2-2001-1376</phone>
      <email>drkhryu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 9, 2016</lastchanged_date>
  <firstreceived_date>July 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kangbuk Samsung Hospital</investigator_affiliation>
    <investigator_full_name>Kyoungho Ryu</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
